Health-related quality of life in a randomized trial of neoadjuvant chemotherapy or chemoradiotherapy plus surgery in patients with oesophageal cancer (NeoRes trial).
B SundeFredrik KlevebroA JoharG JohnsenA-B JacobsenN I GlenjenS FrieslandM LindbladA AjenguiL LundellPernilla LagergrenMagnus NilssonPublished in: The British journal of surgery (2019)
HRQoL after multimodal treatment for cancer of the oesophagus or gastro-oesophageal junction was impaired and more pronounced in patients who underwent nCRT, with only partial recovery over time.
Keyphrases
- neoadjuvant chemotherapy
- papillary thyroid
- locally advanced
- end stage renal disease
- squamous cell
- rectal cancer
- ejection fraction
- newly diagnosed
- chronic kidney disease
- minimally invasive
- clinical trial
- squamous cell carcinoma
- prognostic factors
- study protocol
- sentinel lymph node
- lymph node metastasis
- randomized controlled trial
- coronary artery bypass
- radiation therapy
- peritoneal dialysis
- patient reported outcomes
- pain management
- chronic pain
- acute coronary syndrome
- surgical site infection
- double blind